Byrne, Stephen

Seminar Title: 


University College Cork, School of Pharmacy - Professor of Clinical Pharmacy Practice



1. Current Status, Position

Prof. Stephen Byrne has been appointed Interim Registrar of University College Cork and will commence in the role from the 1st November 2020.  Stephen joined UCC in 2004 and was subsequently appointed to the Chair of Clinical Pharmacy Practice and Head of the School of Pharmacy in October 2013.  For the last two-years Stephen has held the position of Dean of Undergraduate Studies, UCC and has co lead Priorities 2 and 5 of UCC’s Academic Strategy, amongst being an active member of several University Committees including Academic Council, Academic Board, ACRIC and AC Learning and Teaching.

2. Education

Prof. Stephen Byrne graduated from the University of Sunderland (UK) in 1996 with a 1st class Honours Degree in Pharmacy, before embarking on his clinical training in Scotland, Dublin and Limerick. In 2002 he graduated from the School of Pharmacy, Trinity College Dublin having completed his PhD in the area of artificial intelligence and its role in the management of oral anticoagulant therapy.  

3. Research Area

Prof. Stephen Byrne has published over 100 peer review papers and has supervised 20 PhD students during his time in UCC. He has been a co-investigator in three EU funded research projects and as developed a wide network of international collaborators. Among his many research achievements, he is part of a UCC team that developed the STOPP/START criteria which has been endorsed internationally and adapted into treatment pathways for older persons worldwide. His research team have also worked in the field of antimicrobial usage patterns and he was part of a multidisciplinary team to publish the first set of national antimicrobial guidelines for use in primary care in 2011.  Stephen has co-chaired a National Guideline development group, he has acted has conference host/chairperson for international conferences and has actively participated in national meetings and policy development groups.

4. Conflict of interest